VentiRx Pharmaceuticals

Novel Toll-like receptor 8 (TLR8) therapeutics for the treatment of cancer, respiratory, and autoimmune diseases.

Get a Demo and See the Full Profile

Get a demo today to see profiles of VentiRx Pharmaceuticals plus 5979 other startups.

Learn More About VentiRx Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More